Subject: Re: CDC Sponsored EASL 2018 Session on Georgia HCV Elimination
From: "David Sergeenko" <Sergeenko>
To: Averhoff, Francisco (CDC/OID/NCHHSTP) <[email-masked]>
Cc: Gamkrelidze, Amiran (CDC ncdc.ge) <[email-masked]>; Nasrullah, Muazzam (CDC/OID/NCHHSTP) <[email-masked]>; Skaggs, Beth (CDC/CGH/DGHP) <[email-masked]>;
Date: Tue, 30 Jan 2018 08:35:50 +0300

Thank you Francisco !

I really appreciated work with you and the team as your interventions are always efficient and result targeted.

Of course I will do my best to participate the event and will have presentation ready.

Kind Regards

David

Sent from my iPhone

On Jan 29, 2018, at 21:19, Averhoff, Francisco (CDC/OID/NCHHSTP) <[email-masked]> wrote:

Dear Dr. Sergeenko,

Thank you for the call today, I think was very productive.  I would like to ask if you would be amendable to deliver a talk, as per agenda,
Progress towards decentralization and integration of HCV services in primary care, hospitals and harm reduction settings in Georgia. at
upcoming EASL in Paris, April.   Please note that the session has not yet had approval/final from EASL yet, but we are hopeful of approval, and hope you would consider participating.

Best regards, FA

Francisco Averhoff MD, MPH

CAPT US Public Health Service

Associate Director for Global Health

Division of Viral Hepatitis

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

Centers for Disease Control and Prevention

1600 Clifton Road, MS G-37

Atlanta, GA 30333

phone: 404-718-8501

fax: 404-718-8588

e-mail: [email-masked]

_____________________________________________

From: Nasrullah, Muazzam (CDC/OID/NCHHSTP)

Sent: Monday, January 29, 2018 11:15 AM

To: Tom Hemming Karlsen <[email-masked]>; [email-masked]; [email-masked]

Cc: Averhoff, Francisco (CDC/OID/NCHHSTP) <[email-masked]>; [email-masked]

Subject: RE: CDC Sponsored EASL 2018 Session on Georgia HCV Elimination

Importance: High

Dear Dr. Karlsen,

Please find our proposed agenda with speakers for a special session on “Decentralization and Integration of HCV Diagnostics, Care and Treatment Services in Low- and Middle-income Countries”
on Thursday, 12th from 12-13.30. Please confirm on receipt and let me know if you need any more information.

Thanks again for your consideration and looking forward to hear next steps from you/your team.

Muazzam

------------------------------------------------------

Muazzam Nasrullah, MD, MPH, PhD

Global Health Unit | Office of the Director

Division of Viral Hepatitis

National Center for HIV, Hepatitis, STD & TB Prevention

Centers for Disease Control and Prevention (CDC)

1600 Clifton Road, Mailstop G-37, Atlanta, GA 30329

Office: +1 404 639 3271; Fax: +1 404 718 8588

Email: [email-masked]

------------------------------------------------------

-----Original Message-----

From: Tom Hemming Karlsen [mailto:[email-masked]]

Sent: Tuesday, January 23, 2018 4:40 AM

To: Nasrullah, Muazzam (CDC/OID/NCHHSTP) <[email-masked]>; [email-masked]; [email-masked]

Cc: Averhoff, Francisco (CDC/OID/NCHHSTP) <[email-masked]>; [email-masked]

Subject: RE: CDC Sponsored EASL 2018 Session on Georgia HCV Elimination

Dear Muazzam,

We have discussed and there may be a 90 minutes slot on Thursday 12th from

12-13.30 where we could accommodate this request in the official program.

What is not clear to me is what is implicit in the CDC sponsoring, reason for asking we are out of official invitation slots and would need to understand financial implications (travel/housing
mainly, registration less of a problem). Furthermore, to finalize this extra session warrants a rapid turnaround, since we are finalizing the printed congress book these days, and ideally we should receive your draft by the end of this week.

Please let us know how to proceed.

All the best,

Tom

-----Original Message-----

From: Nasrullah, Muazzam (CDC/OID/NCHHSTP) [mailto:[email-masked]]

Sent: Thursday, January 18, 2018 2:52 AM

To: [email-masked]; Tom Hemming Karlsen <[email-masked]>; [email-masked]

Cc: Averhoff, Francisco (CDC/OID/NCHHSTP) <[email-masked]>; 'Nathalie Huguenin' <[email-masked]>;
'Devi Sonida-Mey'

<[email-masked]>; 'Sofia Blomqvist'

<[email-masked]>

Subject: RE: CDC Sponsored EASL 2018 Session on Georgia HCV Elimination

Dear Dr. Karlsen,

Thank you for your email. I will soon be in touch with Devi and Nathalie regarding the side meeting.

Decentralization and integration of HCV diagnostics, care and treatment is a key for elimination, and this proposed CDC-EASL session along with WHO will provide real time examples of decentralization
in different low and middle income countries. At the end of presentations, we may hold a panel discussion highlighting lessons learned and way forward.

I look forward to your encouraging reply.

Best regards,

Muazzam

Sent from handheld device

--------------------------

Muazzam Nasrullah MD, MPH, PhD

Global Health Unit | Office of the Director Division of Viral Hepatitis U.S.

Centers for Disease Control and Prevention (CDC) Atlanta, Georgia

________________________________

From: Tom Hemming Karlsen <[email-masked]>

Date: January 17, 2018 at 8:12:14 PM EST

To: Nasrullah, Muazzam (CDC/OID/NCHHSTP) <[email-masked]>, [email-masked] <[email-masked]>,
[email-masked] <[email-masked]>

Cc: 'Devi Sonida-Mey' <[email-masked]>, 'Nathalie Huguenin'

<[email-masked]>, 'Sofia Blomqvist'

<[email-masked]>

Subject: RE: CDC Sponsored EASL 2018 Session on Georgia HCV Elimination

Dear Nasrullah,

#1 As to reserving a location for the "side meeting" on Georgia (which will not be part of the official program in accordance with previous discussions), please be in touch with Devi Mey and Nathalie
Huguenin in cc.

#2 As to the new proposal, we will discuss and revert to you shortly. Please be aware that the program is quite finalized already, and we have to check for redundancy and room availability.

Yours sincerely,

Tom

----------------------------------------------------------------------------

Prof. Tom Hemming Karlsen

Secretary General

European Association for the Study of the Liver (EASL)

EASL Office – Home of Hepatology

Rue Daubin 7 / CH-1203 Geneva

Switzerland

Mobile: +47 917 22353

E-mail: [email-masked]

Web : www.easl.eu <http://www.easl.eu>

----------------------------------------------------------------------------

-

Tom Hemming Karlsen

MD, PhD, Full Professor of Internal Medicine

Senior Consultant of Gastroenterology and Hepatology

Department of Transplantation Medicine

Oslo University Hospital Rikshospitalet and University of Oslo

PB 4950 Nydalen

N-0424 Oslo

Norway

Tel. +47 91722353

www: http://www.ous-research.no/home/karlsen/Group%20members/6913

----------------------------------------------------------------------------

-----Original Message-----

From: Nasrullah, Muazzam (CDC/OID/NCHHSTP) [mailto:[email-masked]]

Sent: Wednesday, January 17, 2018 5:49 PM

To: Tom Hemming Karlsen <[email-masked]>; [email-masked]; [email-masked]

Cc: Stefano Gnes <[email-masked]>; Fiona Godfrey <[email-masked]>; Nathalie
Huguenin <[email-masked]>; Patricia Pochelon <[email-masked]>; Alexis Schwery <[email-masked]>;
Sofia Blomqvist <[email-masked]>

Subject: FW: CDC Sponsored EASL 2018 Session on Georgia HCV Elimination

Importance: High

Dear all,

Happy New Year!

I came to realize that Gregoire Pavillon has left/retired from EASL. I am forwarding my request to concerned board members. I look forward to the outcome of Board Meeting in December.

Thanks, and best wishes for 2018!

Muazzam

From: Nasrullah, Muazzam (CDC/OID/NCHHSTP)

Sent: Wednesday, December 20, 2017 3:11 PM

To: Gregoire Pavillon <[email-masked]>

Cc: Averhoff, Francisco (CDC/OID/NCHHSTP) <[email-masked]>; Massimo Colombo <[email-masked]>; Stefano Gnes <[email-masked]>;
Fiona Godfrey <[email-masked]>; Nathalie Huguenin <[email-masked]>; Patricia Pochelon <[email-masked]>;
Alexis Schwery <[email-masked]>; Sofia Blomqvist <[email-masked]>; Tom Hemming Karlsen <[email-masked]>

Subject: Fw: CDC Sponsored EASL 2018 Session on Georgia HCV Elimination

Importance: High

Hi Grégoire,

I hope you are well. A few weeks ago we participated in the 3rd Technical Advisory Group (TAG) meeting in Tbilisi, Georgia, where leading international leading experts from different countries
assessed the progress of the Georgia HCV Elimination Program. One of the themes that emerged during TAG was the need to decentralize care and treatment services, including in harm reduction and primary care settings. We convened the first meeting on decentralization
of HCV care and treatment services in Tbilisi, Georgia the week after TAG where key stakeholders, including Ministry of Health, clinicians, laboratorians, CDC, and WHO discussed the way forward.

Given the importance of this topic, not only in Georgia, but internationally, we would like to propose, like last year in Amsterdam, an EASL-CDC “Special Session on Decentralization and Integration
of HCV Diagnostics, Care and Treatment” as part of the program of the International Liver Congress, April 11-15, 2018. I am attaching a draft proposal with topics for presentations.

Additionally, we would like to hold a separate “side meeting” at the congress on “Progress Toward HCV Elimination in Georgia”.

I wanted to make sure that you had these proposed ideas before the EASL Governing Board meeting.

Thanks again for your collaboration and support, I look forward to the outcome of board meeting, and hope the EASL Board will favorably consider these proposals.

Happy Holidays!

Muazzam

------------------------------------------------------

Muazzam Nasrullah, MD, MPH, PhD

Global Health Unit | Office of the Director

Division of Viral Hepatitis

National Center for HIV, Hepatitis, STD & TB Prevention

Centers for Disease Control and Prevention (CDC)

1600 Clifton Road, Mailstop G-37, Atlanta, GA 30329

Office: +1 404 639 3271; Fax: +1 404 718 8588

Email: [email-masked] <mailto:[email-masked]>

------------------------------------------------------

From: Gregoire Pavillon [mailto:[email-masked]]

Sent: Wednesday, October 18, 2017 6:53 AM

To: Nasrullah, Muazzam (CDC/OID/NCHHSTP) <[email-masked] <mailto:[email-masked]>

>

Cc: Averhoff, Francisco (CDC/OID/NCHHSTP) <[email-masked] <mailto:[email-masked]> >; Massimo Colombo <[email-masked]
<mailto:[email-masked]> >; Stefano Gnes <[email-masked] <mailto:[email-masked]> >; Fiona Godfrey <[email-masked]
<mailto:[email-masked]> >; Nathalie Huguenin <[email-masked] <mailto:[email-masked]> >; Patricia Pochelon <[email-masked]
<mailto:[email-masked]> >; Alexis Schwery <[email-masked] <mailto:[email-masked]> >; Sofia Blomqvist <[email-masked]
<mailto:[email-masked]> >

Subject: RE: CDC Sponsored EASL 2018 Session on Georgia HCV Elimination

Dear Prof. Nasrullah,

Please kindly find attached to this email a letter from Prof. Tom Karlsen EASL Secretary General and Prof. Tacke EASL Vice-Secretary General.

Best wishes,

Grégoire

<http://www.easl.eu/>

Grégoire Pavillon <https://www.linkedin.com/in/gpavillon/>  | Executive Director & Governing Board Member

European Association for the Study of the Liver

Address: Rue Daubin 7 | 1203 Geneva | Switzerland <https://www.google.ch/maps/place/Rue+Daubin+7,+1203+Gen%C3%A8ve/@46.206418,

6.1272662,17z/data=!3m1!4b1!4m5!3m4!1s0x478c64cfc469c063:0x318d9380833d58a8!

8m2!3d46.206418!4d6.1294549>

Tel: +41 (0)22 807 03 61 <tel:0041228070361>  | Mob: +41 (0)79 286 68 79 <tel:0041792866879>

Email: [email-masked]

<mailto:[email-masked]>  | Web: www.easl.eu <http://www.easl.eu>
<http://www.easl.eu/>

<https://www.facebook.com/EASLnews/?fref=ts>

<https://twitter.com/EASLnews>

<http://www.linkedin.com/groups/EASL-European-Association-Study-Liver-475369

1/about>    <http://www.youtube.com/user/EASLEurope>

From: Nasrullah, Muazzam (CDC/OID/NCHHSTP) [mailto:[email-masked]]

Sent: mercredi 11 octobre 2017 20:32

To: Gregoire Pavillon <[email-masked] <mailto:[email-masked]> >

Cc: Averhoff, Francisco (CDC/OID/NCHHSTP) <[email-masked] <mailto:[email-masked]> >; Massimo Colombo <[email-masked]
<mailto:[email-masked]> >; Stefano Gnes <[email-masked] <mailto:[email-masked]> >; Fiona Godfrey <[email-masked]
<mailto:[email-masked]> >; Nathalie Huguenin <[email-masked] <mailto:[email-masked]> >; Patricia Pochelon <[email-masked]
<mailto:[email-masked]> >; Alexis Schwery <[email-masked] <mailto:[email-masked]> >

Subject: CDC Sponsored EASL 2018 Session on Georgia HCV Elimination

Importance: High

Dear Dr. Pavillon,

I hope this email finds you well. I wanted to request, as we did during last EASL conference, a “Special Session on HCV Elimination in Georgia” in the upcoming EASL conference in Paris.  See the
attached, our communications with you on the successful session in Amsterdam, and an update on progress/lessons learned, published in MMWR (on World Hepatitis Day this year, July 28), and Nature Review/Gastro (see below links).

*       The Role of Screening and Treatment in National Progress Toward

Hepatitis C Elimination — Georgia, 2015–2016 (https://www.cdc.gov/mmwr/volumes/66/wr/mm6629a2.htm

<https://www.cdc.gov/mmwr/volumes/66/wr/mm6629a2.htm>  )

*       HCV Elimination - Lessons Learned from a Small Eurasian Country,

Georgia

(http://www.nature.com/nrgastro/journal/v14/n8/full/nrgastro.2017.100.html?f

oxtrotcallback=true )

Please let us know if this is possible and, if so, what are the next steps.

We look forward to hearing from you soon.

Best regards,

Muazzam

------------------------------------------------------

Muazzam Nasrullah, MD, MPH, PhD

Global Health Unit | Office of the Director

Division of Viral Hepatitis

National Center for HIV, Hepatitis, STD & TB Prevention

Centers for Disease Control and Prevention (CDC)

1600 Clifton Road, Mailstop G-37, Atlanta, GA 30329

Office: +1 404 639 3271; Fax: +1 404 718 8588

Email: [email-masked] <mailto:[email-masked]>

------------------------------------------------------

<CDC_EASL_Decentralization2018_Draft-v6.docx>